NO862690D0 - Monoklonale antistoffer og antigener for humane ikke-liten-celle lungekarcinomer (nsclc). - Google Patents
Monoklonale antistoffer og antigener for humane ikke-liten-celle lungekarcinomer (nsclc).Info
- Publication number
- NO862690D0 NO862690D0 NO862690A NO862690A NO862690D0 NO 862690 D0 NO862690 D0 NO 862690D0 NO 862690 A NO862690 A NO 862690A NO 862690 A NO862690 A NO 862690A NO 862690 D0 NO862690 D0 NO 862690D0
- Authority
- NO
- Norway
- Prior art keywords
- residues
- lungcarcinomes
- nsclc
- antigens
- cell
- Prior art date
Links
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 208000000649 small cell carcinoma Diseases 0.000 title 1
- 125000003563 glycoside group Chemical group 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 239000001963 growth medium Substances 0.000 abstract 1
- 208000002154 non-small cell lung carcinoma Diseases 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
- 125000005629 sialic acid group Chemical group 0.000 abstract 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3023—Lung
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/863—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgM
- Y10S530/864—Monoclonal
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/866—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving immunoglobulin or antibody fragment, e.g. fab', fab, fv, fc, heavy chain or light chain
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Urology & Nephrology (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Compounds Of Unknown Constitution (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US66752184A | 1984-11-02 | 1984-11-02 | |
| US78517785A | 1985-10-07 | 1985-10-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO862690D0 true NO862690D0 (no) | 1986-07-02 |
Family
ID=27099700
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO862690A NO862690D0 (no) | 1984-11-02 | 1986-07-02 | Monoklonale antistoffer og antigener for humane ikke-liten-celle lungekarcinomer (nsclc). |
Country Status (21)
| Country | Link |
|---|---|
| EP (2) | EP0207090B1 (enExample) |
| JP (3) | JPH0675514B2 (enExample) |
| KR (1) | KR910000903B1 (enExample) |
| AT (1) | ATE117089T1 (enExample) |
| AU (1) | AU599578B2 (enExample) |
| DE (1) | DE3587976T2 (enExample) |
| DK (1) | DK170619B1 (enExample) |
| ES (1) | ES8704735A1 (enExample) |
| FI (1) | FI85814C (enExample) |
| GB (1) | GB2182949B (enExample) |
| GR (1) | GR852622B (enExample) |
| HU (1) | HU208546B (enExample) |
| IE (1) | IE58590B1 (enExample) |
| IL (1) | IL76877A (enExample) |
| NO (1) | NO862690D0 (enExample) |
| NZ (1) | NZ214055A (enExample) |
| OA (1) | OA08354A (enExample) |
| PH (1) | PH24961A (enExample) |
| PT (1) | PT81418B (enExample) |
| WO (1) | WO1986002735A1 (enExample) |
| YU (1) | YU46386B (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4708930A (en) * | 1984-11-09 | 1987-11-24 | Coulter Corporation | Monoclonal antibody to a human carcinoma tumor associated antigen |
| US4906562A (en) * | 1984-12-21 | 1990-03-06 | Oncogen | Monocolonal antibodies and antigen for human non-small cell lung carcinomas |
| JPS61258173A (ja) * | 1985-05-10 | 1986-11-15 | Akira Taniuchi | モノクロ−ナル抗体およびその製法ならびに用途 |
| AU601680B2 (en) * | 1985-05-28 | 1990-09-20 | Joseph P. Brown | Monoclonal antibodies for human non-small cell lung carcinomas |
| US5185432A (en) * | 1986-02-26 | 1993-02-09 | Oncogen | Monoclonal antibodies and antigen for human non-small cell lung carcinoma and other certain human carcinomas |
| JPS6319561A (ja) * | 1986-07-11 | 1988-01-27 | Kyowa Hakko Kogyo Co Ltd | 抗ヒト肺癌単クロ−ン性抗体 |
| US6004761A (en) * | 1986-11-19 | 1999-12-21 | Sanofi | Method for detecting cancer using monoclonal antibodies to new mucin epitopes |
| NZ222509A (en) * | 1986-11-19 | 1993-03-26 | Oncogen | Hybridoma cell line producing antibodies binding to tumour-associated mucin antigen |
| IL89102A0 (en) * | 1988-01-29 | 1989-08-15 | Lilly Co Eli | Vectors,compounds and methods for expression of a human adenocarcinoma antigen |
| AU632469B2 (en) * | 1988-04-04 | 1993-01-07 | Johns Hopkins University, The | A method for early detection of lung cancer |
| US5171665A (en) * | 1989-04-17 | 1992-12-15 | Oncogen | Monoclonal antibody to novel antigen associated with human tumors |
| IT1264490B (it) * | 1992-02-17 | 1996-09-24 | Uni Degli Studi G D Annunzio C | Antigene 90k associato a tumori. |
| JPH0727604U (ja) * | 1993-06-18 | 1995-05-23 | 修司 坂本 | 磁気治療具 |
| EP0695760A1 (en) * | 1994-08-05 | 1996-02-07 | F. Hoffmann-La Roche Ag | Novel tumor marker for lung cancer |
| DE202012001863U1 (de) | 2012-02-22 | 2012-03-19 | Haldex Brake Products Ab | Scheibenbremse und Sensoreinrichtung hierfür |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4172124A (en) | 1978-04-28 | 1979-10-23 | The Wistar Institute | Method of producing tumor antibodies |
| US4906562A (en) * | 1984-12-21 | 1990-03-06 | Oncogen | Monocolonal antibodies and antigen for human non-small cell lung carcinomas |
| JPS61258173A (ja) * | 1985-05-10 | 1986-11-15 | Akira Taniuchi | モノクロ−ナル抗体およびその製法ならびに用途 |
| AU601680B2 (en) * | 1985-05-28 | 1990-09-20 | Joseph P. Brown | Monoclonal antibodies for human non-small cell lung carcinomas |
-
1985
- 1985-10-29 IL IL76877A patent/IL76877A/xx not_active IP Right Cessation
- 1985-10-30 EP EP85905694A patent/EP0207090B1/en not_active Expired - Lifetime
- 1985-10-30 AU AU50691/85A patent/AU599578B2/en not_active Ceased
- 1985-10-30 KR KR1019860700419A patent/KR910000903B1/ko not_active Expired
- 1985-10-30 GB GB8616219A patent/GB2182949B/en not_active Expired
- 1985-10-30 JP JP60505034A patent/JPH0675514B2/ja not_active Expired - Lifetime
- 1985-10-30 PH PH32994A patent/PH24961A/en unknown
- 1985-10-30 DE DE3587976T patent/DE3587976T2/de not_active Expired - Fee Related
- 1985-10-30 WO PCT/US1985/002132 patent/WO1986002735A1/en not_active Ceased
- 1985-10-30 AT AT85905694T patent/ATE117089T1/de not_active IP Right Cessation
- 1985-10-30 HU HU86549A patent/HU208546B/hu not_active IP Right Cessation
- 1985-10-30 EP EP19930106003 patent/EP0566066A1/en not_active Withdrawn
- 1985-10-31 GR GR852622A patent/GR852622B/el unknown
- 1985-10-31 PT PT81418A patent/PT81418B/pt not_active IP Right Cessation
- 1985-10-31 ES ES548421A patent/ES8704735A1/es not_active Expired
- 1985-11-01 IE IE268185A patent/IE58590B1/en not_active IP Right Cessation
- 1985-11-04 NZ NZ214055A patent/NZ214055A/en unknown
- 1985-11-04 YU YU172185A patent/YU46386B/sh unknown
-
1986
- 1986-07-02 DK DK314586A patent/DK170619B1/da not_active IP Right Cessation
- 1986-07-02 FI FI862821A patent/FI85814C/fi not_active IP Right Cessation
- 1986-07-02 NO NO862690A patent/NO862690D0/no unknown
- 1986-07-02 OA OA58895A patent/OA08354A/xx unknown
-
1994
- 1994-01-12 JP JP6001442A patent/JP2567564B2/ja not_active Expired - Lifetime
- 1994-01-12 JP JP6001441A patent/JPH0733400B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Butkowski et al. | Properties of the globular domain of type IV collagen and its relationship to the Goodpasture antigen. | |
| NO862690D0 (no) | Monoklonale antistoffer og antigener for humane ikke-liten-celle lungekarcinomer (nsclc). | |
| Fullmer et al. | Bovine intestinal calcium-binding proteins: Purification and some properties | |
| FI102075B1 (fi) | Menetelmä valmistaa glykosyloitu tai glykosyloimaton polypeptidi, rekombinanttinukleiinihappo ja vektorit | |
| Jander et al. | A collagen-like glycoprotein of the extracellular matrix is the undegraded form of type VI collagen | |
| KR950704489A (ko) | 인터페론 타우 조성물 및 사용방법(interferon tau compositions and methods of use) | |
| ES8703520A1 (es) | Procedimiento de preparar particulas que contienen secuencias de aminoacidos y que tienen propiedades inmunogenas | |
| DK0434605T3 (da) | Ny fremgangsmåde til fremstilling af ikke-fusioneret protein i E.coli | |
| KR910021477A (ko) | 인체 단백질 c의 글리코실화 돌연변이체의 발현을 위한 벡터 및 화합물 | |
| Lester et al. | A postsynthetic modification of human α-fetoprotein controls its immunosuppressive potency | |
| GR3007031T3 (enExample) | ||
| Stathakis et al. | Human fibrinogen heterogeneities. Preparation and characterization of γ and γ′ chains | |
| Novak-Hofer et al. | Two-dimensional separation of chloroplast membrane proteins by isoelectri focusing and electrophoresis in sodium dodecyl sulphate | |
| EP0161095A3 (en) | Vaccine against urinary infection | |
| GR3007909T3 (enExample) | ||
| Beesley et al. | Glycoproteins and glycolipids of oxyntic cell microsomes I. Glycoproteins: Carbohydrate composition, analytical and preparative fractionation | |
| Canicattì et al. | Studies on Holothuriapolii (echinodermata) coelomocyte lysate II. Isolation of coelomocyte hemolysins | |
| DE69529750D1 (de) | Verbesserungen in der herstellung von proteinen in wirtszellen | |
| Shelley et al. | Immunologically related multimeric forms of 30–40 kDa peptides associated with lung surfactant in various mammalian species | |
| Asakawa et al. | Origin of human triosephosphate isomerase isozymes: further evidence for the single structural locus hypothesis with Japanese variants | |
| Alekseeva et al. | Chemical fragmentation by o-iodosobenzoic acid of alpha-chain of histidine decarboxylase from Micrococcus sp. n. AT tryptophan residues. | |
| Schalekamp et al. | Recombination of embryonic haemoglobin chains during the development of the chick | |
| Mohr et al. | Antibodies to interleukin-2 (IL-2) in patients: cross reactivity with different IL-2 species | |
| Strnad et al. | Biochemical characterization of Epstein-Barr virus membrane antigen associated glycoproteins | |
| Trüeb et al. | Type IV collagen is a heteropolymer with the formula C2D |